Q1 2024 13F Holders as of 31 Mar 2024
-
Type / Class
-
Equity / SPONSORED ADR NE
-
Total 13F shares
-
258,944
-
Share change
-
+20,331
-
Total reported value
-
$727,758
-
Price per share
-
$2.81
-
Number of holders
-
5
-
Value change
-
+$57,489
-
Number of buys
-
2
-
Number of sells
-
1
Institutional Holders of XTL BIOPHARMACEUTICALS LTD - SPONSORED ADR NE (XTLB) as of Q1 2024
As of 31 Mar 2024,
XTL BIOPHARMACEUTICALS LTD - SPONSORED ADR NE (XTLB) was held by
5 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
258,944 shares.
The largest 5 holders included
Noked Israel Ltd, MORGAN STANLEY, CITADEL ADVISORS LLC, UBS Group AG, and BNP PARIBAS FINANCIAL MARKETS.
This page lists
5
institutional shareholders reporting positions in this security
for the Q1 2024 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.